“In the field of traditional Chinese patent medicines and simple preparations for the treatment of stable angina pectoris with qi stagnation and blood stasis, experts used the "6+1" dimension evaluation framework to comprehensively evaluate 10 drugs. The results showed that four drugs, including Compound Danshen Dripping Pills and Musk Heart Protecting Pills, were strongly recommended clinically, four drugs, including Quick acting Heart Saving Pills, were weakly recommended, and two drugs, including Lemai Pills, were not recommended temporarily. The study suggests that there is a need to increase research on special populations, pharmacokinetic parameters, and other aspects to provide more comprehensive evidence-based support.”